Humacyte (HUMA) Capital Leases (2020 - 2026)

Humacyte (HUMA) has 7 years of Capital Leases data on file, last reported at $27.6 million in Q1 2026.

• Capital Leases for Q1 2026 came in at $27.6 million, up 114.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $27.6 million (up 114.9% YoY), and the FY2025 annual result was $27.0 million, up 98.05% from the prior year.
• Capital Leases improved to $27.6 million in Q1 2026 per HUMA's latest filing, from $27.0 million in the prior quarter.
• Over five years, Capital Leases peaked at $27.6 million in Q1 2026 and troughed at $12.0 million in Q2 2025.
• A 5-year average of $18.4 million and a median of $17.6 million in 2023 frame the typical range for Capital Leases.
• The sharpest annual moves came in 2025 and 2026: Capital Leases retreated 20.45% in 2025, then surged 114.9% in 2026.
• A 5-year view of Capital Leases shows it stood at $18.9 million in 2022, then declined by 13.58% to $16.3 million in 2023, then dropped by 16.41% to $13.6 million in 2024, then soared by 98.05% to $27.0 million in 2025, then grew by 2.33% to $27.6 million in 2026.
• Business Quant data shows HUMA's Capital Leases at $27.6 million in Q1 2026, $27.0 million in Q4 2025, and $27.2 million in Q3 2025.